Psychiatric DisorderSORTNCT04249960
Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study.
A study testing Managed transition in people with Psychiatric Disorder and Transition, run by University of Geneva, Switzerland at 1 site in Switzerland.
Trial summary
Disruption of care during transition from child and adolescent mental health (CAMHS) to adult mental health services (AMHS) may adversely affect the health and well-being of service users. Indeed, transition-related discontinuity of care is a major health and societal challenge today. Read more about this study
- Who is it for?
- Ages 16 to 18 years
- Conditions the study is for
- Psychiatric Disorder, Transition
- What is being tested?
- Managed transition
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteSwitzerland
- Study dates
- 9 Oct 2019to 28 Feb 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- 1) provides valid written informed consent, or assent, if below the legal age of consent;
- 2) age is within 18 months of reaching the transition boundary of their CAMHS - during the trial recruitment period;
- 3) has a mental disorder defined by DSM-IV-TR, DSM-5 or ICD 10/11, or is under the regular care of CAMHS (if not yet diagnosed);
- 4) Has an IQ ≥ 70 as ascertained by previous standardized assessment or diagnosed by clinician, or no indication of intellectual impairment.
Who cannot join
- 1) does not provide valid written informed consent, or assent, if below the legal age of consent;
- 2) is younger than 18 months before the transition boundary of their CAMHS;
- 3) has intellectual impairment (IQ < 70) as ascertained by standardized assessment or diagnosed by clinician;
- 4) if not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant.
Trial locations and contacts
1 site in 1 country.
Switzerland1 site, 1 recruiting
- Recruiting
University of Geneva
Geneva, 1211
Marco Armando, MD, PhD, 0041223886756, Marco.Armando@unige.ch
About this study
Disruption of care during transition from child and adolescent mental health (CAMHS) to adult mental health services (AMHS) may adversely affect the health and well-being of service users. Indeed, transition-related discontinuity of care is a major health and societal challenge today. Current evidences show that this transition is not always properly managed and that improving the transition process can have a positive impact on the health and wellbeing of young people. Nevertheless, data available are still inconsistent and only few studies investigated possible models aimed at improving and operationalize the transition. At present, no information concerning the transition in the Geneva Canton is available.
According to this lack of evidence, the current study aims at: 1) mapping the CAMHS/AMHS interface; 2) evaluating the longitudinal course and outcomes of adolescents approaching the transition boundary (TB) of their CAMHS; 3) determining the effectiveness of an experimental model of managed transition in improving outcomes, compared with usual care; 4) comparing these results with those of the EU funded MILESTONE study from several other European countries.
The investigators will recruit all patients aged ≥ 16 years and 6 months from the Geneva Canton in charge at CAMHS and they will follow them for up to 24 months. CAMHS will be instructed to provide all their service users at the time of transition either usual care or a novel service called "Managed Transition", which will include the use of a new decision support tool, the Transition Readiness and Appropriateness Measure (TRAM). A nested cohort Randomised Controlled Trial (ncRCT) design will be applied to divide patients into the two groups. The health and wellbeing of the young people will be assessed at baseline and then followed-up for 24 months to see whether they transition to AMHS or are discharged or referred to some other service. The investigators will then evaluate what impact the different transition experiences have on young people's health and wellbeing, and whether the process of Managed Transition has any benefits as compared to usual care.
- Conditions
- Psychiatric Disorder, Transition
- Being tested
- Managed transition
- Keywords
- adolescents, psychiatric disorders, CAMHS, AMHS, transition
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Managed transitionBehavioural
Young people, their family and clinicians will receive transition guidelines and will be asked to follow them as much as possible.
| Study group | Role | What they receive |
|---|---|---|
| Transition as usual | No intervention | Young people in this group will receive usual care and transition as usual, they will be our control group. |
| Managed transition | Experimental | Young people in this group will do the managed transition, they will be our experimental group. Receives: Behavioral: Managed transition |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient's health status (need for care)
Measured at each time point using the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) completed by a trained research assistant. Scores will be compared between first and last time point. HoNOSCA is 5 point scale going from 0 = not a problem, 1 = minor issue not requiring intervention, 2 = slightly problematic, 3 = moderately serious problem, 4 = serious to very serious problem, 9= unknown/not applicable. Scores are calculated by adding up all the subscales (9s are not counted) and a higher score means a worse outcome.
Measured: Before transition compared to after transition (18 months)
Secondary outcomes (18)
Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) self report
Self-report "need for care" status measured by the Health of the Nation Outcome Scale for Children and Adolescents
Measured: Baseline, 6, 12 and 18 months
Transition Related Outcome Measure (TROM)
Transition Related Outcome Measure to assess outcomes post-transition completed by the young person, parent/carer and clinician
Measured: 6, 12 or 18 months
Child Behavior Checklist (CBCL) or Adult Behavior Checklist (ABCL)
Emotional and behavioral disturbances measured by the Achenbach System of Empirically Based Assessment (ASEBA) Child Behavior Checklist (CBCL) or Adult Behavior Checklist (ABCL) questionnaires (parent/carer version). CBCL targets young people until 17 and ABCL after 17.
Measured: Baseline and 18 months
Clinical Global Impression Scale (CGIS)
The Clinical Global Impression Scale completed by the clinician assesses patient's ilness severity
Measured: Baseline, 6, 12 and 18 months
World Health Organisation's quality of life (WHOQOL-BREF)
Young person's quality of life is measured by World Health Organisation's quality of life questionnaire. It is completed by the young person.
Measured: Baseline and 18 months
EuroQol generic quality of life questionnaire (5Q-5D-5L)
Quality Adjusted Life Years (QALYs) and cost effectiveness are assessed by EuroQol generic quality of life questionnaire completed by the young person.
Measured: Baseline, 6, 12 and 18 months
On Your Own Feet - Transition Experience Scale (OYOF-TES)
Transition experience and readiness assessed by On Your Own Feet - Transition Experience Scale completed by the young person and parent/carer only once at the time point right after transition
Measured: 6, 12 or 18 months
Barriers to Care (BtC)
Barriers to care assessed by Barriers to Care checklist completed by the young person if he/she is not using the available services any more
Measured: 6, 12 and 18 months
Client Service Receipt Inventory (CSRI)
Service use assessed by a Client Service Receipt Inventory adapted from the Milestone study; completed by the young person
Measured: Baseline, 6, 12 and 18 months
Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) clinician version
Need for care and mental health status measured by Health of the Nation Outcome Scale for Children and Adolescents completed by a trained research assistant with information from the young person, parent/carer and clinician to ensure accuracy
Measured: Baseline, 6, 12, and 18 months
Kiddie Schedule for Affective Disorders and Schizophrenia-Present State and Lifetime (K-SADS-PL)
Kiddie Schedule for Affective Disorders and Schizophrenia-Present State and Lifetime Version for DSM-IV performed by a trained research assistant
Measured: Baseline and 18 months
Prodromal questionnaire (PQ-16)
Prodromal questionnaire to assess prodromal symptoms filled by the young person as a self report
Measured: Baseline and 18 months
General Assessment Scale for Social Functioning (GASC)
General Assessment Scale for Social Functioning assesses patients general functioning filled by the clinician
Measured: Baseline and 18 months
Reflective Functioning Questionnaire (RFQ and PRFQ) self-report and parent version
Reflective Functioning Questionnaire assesses mentalisation abilities filled by the young person and parent/carer (two versions)
Measured: Baseline
Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS)
Social abilities are measured by the Anticipatory and Consummatory Interpersonal Pleasure Scale self report and parent/carer version
Measured: Baseline
Multidimensional Peer Victimization Scale-Revised (MPVS-R)
Multidimensional Peer Victimization Scale-Revised assesses bullying as a self report
Measured: Baseline and 18 months
Coddington Life Event Scale (CLES)
Important life events is assessed by the Coddington Life Event Scale self-report
Measured: Baseline, 6, 12 and 18 months
Perceived Stress Reactivity Scale (PSRS)
Young person's stress status is measured by the Perceived Stress Reactivity Scale self report
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jan 2020
- Study start9 Oct 2019
- Primary completion1 Sep 2021 (estimated)
- Study completion28 Feb 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (44)Papers the sponsor has linked to this study.
- Other trials for Psychiatric DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Geneva, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr Marco Armando, University of Geneva, Switzerland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04249960
- Sponsor's protocol ID
- 2019-0853
- Acronym
- SORT
- Status last verified
- Jan 2020
- First submitted
- 14 Nov 2019
- Last updated
- 31 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Waylen A, Wolke D. Sex 'n' drugs 'n' rock 'n' roll: the meaning and social consequences of pubertal timing. Eur J Endocrinol. 2004 Nov;151 Suppl 3:U151-9. doi: 10.1530/eje.0.151u151.
PubMed 15554900Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
PubMed 15939839McGorry PD. The specialist youth mental health model: strengthening the weakest link in the public mental health system. Med J Aust. 2007 Oct 1;187(S7):S53-6. doi: 10.5694/j.1326-5377.2007.tb01338.x.
PubMed 17908028McGorry P. Transition to adulthood: the critical period for pre-emptive, disease-modifying care for schizophrenia and related disorders. Schizophr Bull. 2011 May;37(3):524-30. doi: 10.1093/schbul/sbr027.
PubMed 21505119Pottick KJ, Bilder S, Vander Stoep A, Warner LA, Alvarez MF. US patterns of mental health service utilization for transition-age youth and young adults. J Behav Health Serv Res. 2008 Oct;35(4):373-89. doi: 10.1007/s11414-007-9080-4. Epub 2007 Nov 17.
PubMed 18026842Kataoka SH, Zhang L, Wells KB. Unmet need for mental health care among U.S. children: variation by ethnicity and insurance status. Am J Psychiatry. 2002 Sep;159(9):1548-55. doi: 10.1176/appi.ajp.159.9.1548.
PubMed 12202276Forbes A, While A, Ullman R, et al. A multi-method review to identify components of practice which may promote continuity in the transition from child to adult care for young people with chronic illness or disability. Report for the National Coordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). London, UK: The Florence Nightingale School of Nursing and Midwifery, King's College, 2002.
Kennedy A, Sloman F, Douglass JA, Sawyer SM. Young people with chronic illness: the approach to transition. Intern Med J. 2007 Aug;37(8):555-60. doi: 10.1111/j.1445-5994.2007.01440.x.
PubMed 17640188Kennedy P, Pugh R, Millar E. Towards managing the whole system of care and improving continuity of care. Psychiatric Bulletin, 29(7): 252-254, 2005
Davis M. Addressing the needs of youth in transition to adulthood. Adm Policy Ment Health. 2003 Jul;30(6):495-509. doi: 10.1023/a:1025027117827.
PubMed 13677456Singh S P, Paul M, Islam Z, et al. Transition from CAMHS to adult mental health services (TRACK): a study of service organisation, policies, process and user and carer perspectives. 2010. Report for the national institute for health research service delivery and organisation programme (SDO Project 08/1613/117).
Wilson A, Tuffrey A, McKenzie C, Street C. After the flood: young people's perspectives on transition. Lancet Psychiatry. 2015 May;2(5):376-378. doi: 10.1016/S2215-0366(15)00126-1. Epub 2015 Apr 28. No abstract available.
PubMed 26360268Paul M, Street C, Wheeler N, Singh SP. Transition to adult services for young people with mental health needs: A systematic review. Clin Child Psychol Psychiatry. 2015 Jul;20(3):436-57. doi: 10.1177/1359104514526603. Epub 2014 Apr 7.
PubMed 24711585Hovish K, Weaver T, Islam Z, Paul M, Singh SP. Transition experiences of mental health service users, parents, and professionals in the United Kingdom: a qualitative study. Psychiatr Rehabil J. 2012 Winter;35(3):251-7. doi: 10.2975/35.3.2012.251.257.
PubMed 22246124McDonagh JE, Viner RM. Lost in transition? Between paediatric and adult services. BMJ. 2006 Feb 25;332(7539):435-6. doi: 10.1136/bmj.332.7539.435. No abstract available.
PubMed 16497736
Study at a glance
From the registry record, last updated by the sponsor on 31 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study.
- ClinicalTrials.gov ID
- NCT04249960
- Acronym / sponsor ID
- SORT / 2019-0853
- Conditions
- Psychiatric Disorder, Transition
- Keywords
- adolescents, psychiatric disorders, CAMHS, AMHS, transition
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of Geneva, SwitzerlandUniversity, hospital or other
- Study start
- 9 Oct 2019 (actual)
- Primary completion
- 1 Sep 2021 (estimated)
- Study completion
- 28 Feb 2022 (estimated)
- First posted
- 31 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Disruption of care during transition from child and adolescent mental health (CAMHS) to adult mental health services (AMHS) may adversely affect the health and well-being of service users. Indeed, transition-related discontinuity of care is a major health and societal challenge today. Current evidences show that this transition is not always properly managed and that improving the transition process can have a positive impact on the health and wellbeing of young people. Nevertheless, data available are still inconsistent and only few studies investigated possible models aimed at improving and operationalize the transition. At present, no information concerning the transition in the Geneva Canton is available.
According to this lack of evidence, the current study aims at: 1) mapping the CAMHS/AMHS interface; 2) evaluating the longitudinal course and outcomes of adolescents approaching the transition boundary (TB) of their CAMHS; 3) determining the effectiveness of an experimental model of managed transition in improving outcomes, compared with usual care; 4) comparing these results with those of the EU funded MILESTONE study from several other European countries.
The investigators will recruit all patients aged ≥ 16 years and 6 months from the Geneva Canton in charge at CAMHS and they will follow them for up to 24 months. CAMHS will be instructed to provide all their service users at the time of transition either usual care or a novel service called "Managed Transition", which will include the use of a new decision support tool, the Transition Readiness and Appropriateness Measure (TRAM). A nested cohort Randomised Controlled Trial (ncRCT) design will be applied to divide patients into the two groups. The health and wellbeing of the young people will be assessed at baseline and then followed-up for 24 months to see whether they transition to AMHS or are discharged or referred to some other service. The investigators will then evaluate what impact the different transition experiences have on young people's health and wellbeing, and whether the process of Managed Transition has any benefits as compared to usual care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Transition as usual | No intervention | –Young people in this group will receive usual care and transition as usual, they will be our control group. |
| Managed transition | Experimental | Behavioral: Managed transitionYoung people in this group will do the managed transition, they will be our experimental group. |
Who may qualify
- Ages
- 16 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- 1) provides valid written informed consent, or assent, if below the legal age of consent;
- 2) age is within 18 months of reaching the transition boundary of their CAMHS - during the trial recruitment period;
- 3) has a mental disorder defined by DSM-IV-TR, DSM-5 or ICD 10/11, or is under the regular care of CAMHS (if not yet diagnosed);
- 4) Has an IQ ≥ 70 as ascertained by previous standardized assessment or diagnosed by clinician, or no indication of intellectual impairment.
Key exclusion criteria (4 listed)
- 1) does not provide valid written informed consent, or assent, if below the legal age of consent;
- 2) is younger than 18 months before the transition boundary of their CAMHS;
- 3) has intellectual impairment (IQ < 70) as ascertained by standardized assessment or diagnosed by clinician;
- 4) if not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Managed transitionYoung people, their family and clinicians will receive transition guidelines and will be asked to follow them as much as possible. | Behavioural | Managed transition |
Primary outcome
Patient's health status (need for care)
Time frame: Before transition compared to after transition (18 months)
Measured at each time point using the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) completed by a trained research assistant. Scores will be compared between first and last time point. HoNOSCA is 5 point scale going from 0 = not a problem, 1 = minor issue not requiring intervention, 2 = slightly problematic, 3 = moderately serious problem, 4 = serious to very serious problem, 9= unknown/not applicable. Scores are calculated by adding up all the subscales (9s are not counted) and a higher score means a worse outcome.
18 secondary outcomes
Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) self report
Time frame: Baseline, 6, 12 and 18 months
Transition Related Outcome Measure (TROM)
Time frame: 6, 12 or 18 months
Child Behavior Checklist (CBCL) or Adult Behavior Checklist (ABCL)
Time frame: Baseline and 18 months
Clinical Global Impression Scale (CGIS)
Time frame: Baseline, 6, 12 and 18 months
World Health Organisation's quality of life (WHOQOL-BREF)
Time frame: Baseline and 18 months
EuroQol generic quality of life questionnaire (5Q-5D-5L)
Time frame: Baseline, 6, 12 and 18 months
On Your Own Feet - Transition Experience Scale (OYOF-TES)
Time frame: 6, 12 or 18 months
Barriers to Care (BtC)
Time frame: 6, 12 and 18 months
Client Service Receipt Inventory (CSRI)
Time frame: Baseline, 6, 12 and 18 months
Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) clinician version
Time frame: Baseline, 6, 12, and 18 months
Kiddie Schedule for Affective Disorders and Schizophrenia-Present State and Lifetime (K-SADS-PL)
Time frame: Baseline and 18 months
Prodromal questionnaire (PQ-16)
Time frame: Baseline and 18 months
General Assessment Scale for Social Functioning (GASC)
Time frame: Baseline and 18 months
Reflective Functioning Questionnaire (RFQ and PRFQ) self-report and parent version
Time frame: Baseline
Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS)
Time frame: Baseline
Multidimensional Peer Victimization Scale-Revised (MPVS-R)
Time frame: Baseline and 18 months
Coddington Life Event Scale (CLES)
Time frame: Baseline, 6, 12 and 18 months
Perceived Stress Reactivity Scale (PSRS)
Time frame: Baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jan 2020.
- Background: PubMed 15554900Waylen A, Wolke D. Sex 'n' drugs 'n' rock 'n' roll: the meaning and social consequences of pubertal timing. Eur J Endocrinol. 2004 Nov;151 Suppl 3:U151-9. doi: 10.1530/eje.0.151u151.
- Background: PubMed 15939839Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
- Background: PubMed 17908028McGorry PD. The specialist youth mental health model: strengthening the weakest link in the public mental health system. Med J Aust. 2007 Oct 1;187(S7):S53-6. doi: 10.5694/j.1326-5377.2007.tb01338.x.
- Background: PubMed 21505119McGorry P. Transition to adulthood: the critical period for pre-emptive, disease-modifying care for schizophrenia and related disorders. Schizophr Bull. 2011 May;37(3):524-30. doi: 10.1093/schbul/sbr027.
- Background: PubMed 18026842Pottick KJ, Bilder S, Vander Stoep A, Warner LA, Alvarez MF. US patterns of mental health service utilization for transition-age youth and young adults. J Behav Health Serv Res. 2008 Oct;35(4):373-89. doi: 10.1007/s11414-007-9080-4. Epub 2007 Nov 17.
- Background: PubMed 12202276Kataoka SH, Zhang L, Wells KB. Unmet need for mental health care among U.S. children: variation by ethnicity and insurance status. Am J Psychiatry. 2002 Sep;159(9):1548-55. doi: 10.1176/appi.ajp.159.9.1548.
- BackgroundForbes A, While A, Ullman R, et al. A multi-method review to identify components of practice which may promote continuity in the transition from child to adult care for young people with chronic illness or disability. Report for the National Coordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). London, UK: The Florence Nightingale School of Nursing and Midwifery, King's College, 2002.
- Background: PubMed 17640188Kennedy A, Sloman F, Douglass JA, Sawyer SM. Young people with chronic illness: the approach to transition. Intern Med J. 2007 Aug;37(8):555-60. doi: 10.1111/j.1445-5994.2007.01440.x.
- BackgroundKennedy P, Pugh R, Millar E. Towards managing the whole system of care and improving continuity of care. Psychiatric Bulletin, 29(7): 252-254, 2005
- Background: PubMed 13677456Davis M. Addressing the needs of youth in transition to adulthood. Adm Policy Ment Health. 2003 Jul;30(6):495-509. doi: 10.1023/a:1025027117827.
- BackgroundSingh S P, Paul M, Islam Z, et al. Transition from CAMHS to adult mental health services (TRACK): a study of service organisation, policies, process and user and carer perspectives. 2010. Report for the national institute for health research service delivery and organisation programme (SDO Project 08/1613/117).
- Background: PubMed 26360268Wilson A, Tuffrey A, McKenzie C, Street C. After the flood: young people's perspectives on transition. Lancet Psychiatry. 2015 May;2(5):376-378. doi: 10.1016/S2215-0366(15)00126-1. Epub 2015 Apr 28. No abstract available.
- UK Guidelines on transition in mental healthLink provided by the sponsor.
- NICE Guidelines on transition in mental healthLink provided by the sponsor.
Related trials for Psychiatric Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Managed transition in people with Psychiatric Disorder and Transition, run by University of Geneva, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marco Armando, MD, PhD (+41 22 388 67 56, Marco.Armando@unige.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient's health status (need for care) (time frame: Before transition compared to after transition (18 months)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04249960, which also lists 44 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2020.